Table of Content

1 Continuous Subcutaneous Insulin Infusion Devices Market Overview
1.1 Product Overview and Scope of Continuous Subcutaneous Insulin Infusion Devices
1.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
1.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Normal Pump
1.2.3 Patch Pump
1.3 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
1.3.1 Continuous Subcutaneous Insulin Infusion Devices Sales Comparison by Application: (2021-2027)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Estimates and Forecasts
1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue 2016-2027
1.4.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales 2016-2027
1.4.3 Continuous Subcutaneous Insulin Infusion Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Continuous Subcutaneous Insulin Infusion Devices Market Competition by Manufacturers
2.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Continuous Subcutaneous Insulin Infusion Devices Manufacturing Sites, Area Served, Product Type
2.5 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation and Trends
2.5.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players Market Share by Revenue
2.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario by Region
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.3.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
3.3.2 North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.4.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country
3.4.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region
3.5.2 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.6.1 Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country
3.6.2 Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country
3.7.2 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Continuous Subcutaneous Insulin Infusion Devices Historic Market Analysis by Type
4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2016-2021)
4.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2016-2021)
4.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2016-2021)

5 Global Continuous Subcutaneous Insulin Infusion Devices Historic Market Analysis by Application
5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2016-2021)
5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2016-2021)
5.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Roche Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Insulet Corp
6.3.1 Insulet Corp Corporation Information
6.3.2 Insulet Corp Description and Business Overview
6.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Insulet Corp Product Portfolio
6.3.5 Insulet Corp Recent Developments/Updates
6.4 Tandem Diabetes care
6.4.1 Tandem Diabetes care Corporation Information
6.4.2 Tandem Diabetes care Description and Business Overview
6.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Tandem Diabetes care Product Portfolio
6.4.5 Tandem Diabetes care Recent Developments/Updates
6.5 Valeritas
6.5.1 Valeritas Corporation Information
6.5.2 Valeritas Description and Business Overview
6.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Valeritas Product Portfolio
6.5.5 Valeritas Recent Developments/Updates
6.6 SOOIL
6.6.1 SOOIL Corporation Information
6.6.2 SOOIL Description and Business Overview
6.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 SOOIL Product Portfolio
6.6.5 SOOIL Recent Developments/Updates
6.7 Microport
6.6.1 Microport Corporation Information
6.6.2 Microport Description and Business Overview
6.6.3 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Microport Product Portfolio
6.7.5 Microport Recent Developments/Updates

7 Continuous Subcutaneous Insulin Infusion Devices Manufacturing Cost Analysis
7.1 Continuous Subcutaneous Insulin Infusion Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
7.4 Continuous Subcutaneous Insulin Infusion Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Continuous Subcutaneous Insulin Infusion Devices Distributors List
8.3 Continuous Subcutaneous Insulin Infusion Devices Customers

9 Continuous Subcutaneous Insulin Infusion Devices Market Dynamics
9.1 Continuous Subcutaneous Insulin Infusion Devices Industry Trends
9.2 Continuous Subcutaneous Insulin Infusion Devices Growth Drivers
9.3 Continuous Subcutaneous Insulin Infusion Devices Market Challenges
9.4 Continuous Subcutaneous Insulin Infusion Devices Market Restraints

10 Global Market Forecast
10.1 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Type (2022-2027)
10.2 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Application (2022-2027)
10.3 Continuous Subcutaneous Insulin Infusion Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Continuous Subcutaneous Insulin Infusion Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Continuous Subcutaneous Insulin Infusion Devices Covered in This Study
Table 5. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Continuous Subcutaneous Insulin Infusion Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Continuous Subcutaneous Insulin Infusion Devices Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Continuous Subcutaneous Insulin Infusion Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Continuous Subcutaneous Insulin Infusion Devices Product Type
Table 12. Global Continuous Subcutaneous Insulin Infusion Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Continuous Subcutaneous Insulin Infusion Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Continuous Subcutaneous Insulin Infusion Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2016-2021)
Table 17. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2016-2021)
Table 20. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2016-2021)
Table 40. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Type (2016-2021)
Table 42. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Type (2016-2021)
Table 43. Global Continuous Subcutaneous Insulin Infusion Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2016-2021)
Table 45. Global Continuous Subcutaneous Insulin Infusion Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Application (2016-2021)
Table 47. Global Continuous Subcutaneous Insulin Infusion Devices Price (US$/Unit) by Application (2016-2021)
Table 48. Medtronic Corporation Information
Table 49. Medtronic Description and Business Overview
Table 50. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product
Table 52. Medtronic Recent Developments/Updates
Table 53. Roche Corporation Information
Table 54. Roche Description and Business Overview
Table 55. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Roche Continuous Subcutaneous Insulin Infusion Devices Product
Table 57. Roche Recent Developments/Updates
Table 58. Insulet Corp Corporation Information
Table 59. Insulet Corp Description and Business Overview
Table 60. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product
Table 62. Insulet Corp Recent Developments/Updates
Table 63. Tandem Diabetes care Corporation Information
Table 64. Tandem Diabetes care Description and Business Overview
Table 65. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product
Table 67. Tandem Diabetes care Recent Developments/Updates
Table 68. Valeritas Corporation Information
Table 69. Valeritas Description and Business Overview
Table 70. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product
Table 72. Valeritas Recent Developments/Updates
Table 73. SOOIL Corporation Information
Table 74. SOOIL Description and Business Overview
Table 75. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product
Table 77. SOOIL Recent Developments/Updates
Table 78. Microport Corporation Information
Table 79. Microport Description and Business Overview
Table 80. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Microport Continuous Subcutaneous Insulin Infusion Devices Product
Table 82. Microport Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Continuous Subcutaneous Insulin Infusion Devices Distributors List
Table 86. Continuous Subcutaneous Insulin Infusion Devices Customers List
Table 87. Continuous Subcutaneous Insulin Infusion Devices Market Trends
Table 88. Continuous Subcutaneous Insulin Infusion Devices Growth Drivers
Table 89. Continuous Subcutaneous Insulin Infusion Devices Market Restraints
Table 90. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Continuous Subcutaneous Insulin Infusion Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Continuous Subcutaneous Insulin Infusion Devices
Figure 2. Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Type in 2020 & 2027
Figure 3. Normal Pump Product Picture
Figure 4. Patch Pump Product Picture
Figure 5. Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Application in 2020 & 2027
Figure 6. Type I Diabetes
Figure 7. Type II Diabetes
Figure 8. Global Continuous Subcutaneous Insulin Infusion Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Continuous Subcutaneous Insulin Infusion Devices Market Size 2016-2027 (US$ Million)
Figure 10. Global Continuous Subcutaneous Insulin Infusion Devices Sales 2016-2027 (K Units)
Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Continuous Subcutaneous Insulin Infusion Devices Sales Share by Manufacturers in 2020
Figure 13. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Continuous Subcutaneous Insulin Infusion Devices Players: Market Share by Revenue in 2020
Figure 15. Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2016-2021)
Figure 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region in 2020
Figure 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2016-2021)
Figure 19. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region in 2020
Figure 20. U.S. Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Continuous Subcutaneous Insulin Infusion Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Type (2016-2021)
Figure 45. Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Application (2016-2021)
Figure 46. Sales Market Share of Continuous Subcutaneous Insulin Infusion Devices by Application in 2020
Figure 47. Revenue Share of Continuous Subcutaneous Insulin Infusion Devices by Application (2016-2021)
Figure 48. Revenue Share of Continuous Subcutaneous Insulin Infusion Devices by Application in 2020
Figure 49. Manufacturing Cost Structure of Continuous Subcutaneous Insulin Infusion Devices
Figure 50. Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
Figure 51. Continuous Subcutaneous Insulin Infusion Devices Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed